The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

A new nanomedicine drug delivery system improves chemotherapy targeting for choriocarcinoma, shrinking tumors by 95% in mouse models. Researchers engineered polymersomes to enhance methotrexate (MTX) ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced a positive update ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

The Department of Robotics and Mechatronics Engineering research team at the Daegu Gyeongbuk Institute of Science and ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal Orthopaedic Hospital has secured a £110,000 grant from Orthopaedic Research UK to ...

Biomaterials Market, substances engineered to interact with biological systems for medical and therapeutic purposes, are revolutionizing healthcare. These materials are biocompatible and find ...

Their discovery, published in the June 14 issue of Science Advances, offers new hope for improving the longevity and function ...

Nanovis announced today that it sold certain nano surface technology assets and certain IP rights to Medtronic.

The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year ...

The port delivery system (PDS) implant is about the size of a grain of rice, is refillable and delivers the drug continuously for at least six months, so patients can manage wet AMD with just two ...